Skip to content
Blerp – Lifestyle
Author:
Kalohexis
Cosmetic Physician Partners Welcomes Sullivan Surgery & Spa to Its National Network
September 3, 2026
Kalohexis Appoints Garry Menzel, Ph.D., to Board of Directors
September 1, 2026
Cosmetic Physician Partners Ranks in Top 10% of 2026 Inc. 5000 List of Fastest-Growing Private Companies
August 12, 2026
Kalohexis Appoints Life Sciences Leader, Jeffrey Sherman, MD, to Board of Directors
August 11, 2026
Cosmetic Physician Partners Pays Out $35 Million: Putting Cash Directly in the Hands of Its Doctors, Nurses and Employees
July 23, 2026
Kalohexis Presents Data Demonstrating Dual MC3R/MC4R Activation Drives Weight Loss, Limits Rebound, and Preserves Lean Mass in Obese Nonhuman Primates at ICO 2026
July 15, 2026
Kalohexis Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
July 7, 2026
Kalohexis Appoints Xuan Hui, B.Med., M.S., Ph.D., as Director of Corporate Strategy
June 18, 2026
Kalohexis Presents Data Highlighting Dual MC3R/MC4R Activation as a Novel Mechanism Designed to Drive Safer, Healthier and More Durable Weight Loss at ENDO 2026
June 15, 2026
Kalohexis Announces Publication in Nature Communications Highlighting Dual MC3R/MC4R Activation as a Novel, Durable Mechanism that Drives Weight Loss
May 29, 2026
1
2
Next Page
→